Transaction · 0001193125-26-221926

Staab Thomas R II

STAAB THOMAS R II, CFO, reported a transaction classified as grant at TENAX THERAPEUTICS, INC. involving 450000.000000 shares for an estimated $0.00. Reported holdings after the transaction were 450000.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code ACFO
TENXTENAX THERAPEUTICS, INC.
Trade date
May 11, 2026
Filing date
May 13, 2026
View on SEC Insider profile
Disclosed value$0Shares × reported price
Shares traded450k$0.00 per share
Holdings after450kDirect
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

TENX price since this filing

Daily closing prices, with the filing date and available return windows
TENX · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago1d ago
Returns since7d30d90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
grant
Code A
Identifier
0001193125-26-221926
Stock Option (right to buy)
Transaction date
May 11, 2026
Filed May 13, 2026, 09:08 PM · 2d delay
Shares
450,000 sh
$0.00 per share
Estimated value
$0
Computed from shares × price
Holdings after
450,000 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Derivative Transaction Direct Ownership Large Holdings Increase
Filing-only score

-6 points

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • timely_filing+4 points

    reporting_delay_days = 2

    Filing reported within two business days of the transaction.
  • derivative_transaction-16 points

    is_derivative = true

    Derivative exercise rows are less discretionary than open-market purchases.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Financial Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Represents a restricted stock award which vests 25% ten days after the grant date, with the remainder vesting in three equal installments on the four-month, eight-month and twelve-month anniversaries…

  2. F2

    The options vest and become exercisable as follows: 25% vest on May 11, 2027, and thereafter, the remainder vest in substantially equal installments on each monthly anniversary of the grant date for a…

Original filing · 0001193125-26-221926
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

TENX